The Digital Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for digital biomarkers has seen a significant expansion in the past years. It expanded from $3.92 billion in 2024 to $4.96 billion in 2025, indicating a compound annual growth rate (CAGR) of 26.3%.
The Digital Biomarkers Global Market Report 2025 predicts the market will expand to $12.52 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 26.1%.
Download Your Free Sample of the 2025 Digital Biomarkers Market Report and Uncover Key Trends Now!The key drivers in the digital biomarkers market are:
• Increasing adoption of digital biomarkers by healthcare providers
• Rising prevalence of chronic diseases, leading to higher demand
• Growth in consumer awareness and interest in fitness and lifestyle monitoring
• Advancements in wearable technology and its integration with artificial intelligence
The digital biomarkersmarket covered in this report is segmented –
1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types
2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices
3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications
4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users
The key trends in the digital biomarkers market are:
• Advancements in wearable technology are becoming a key trend in the market.
• Integration with artificial intelligence is increasingly shaping the digital biomarkers industry.
• The market is witnessing a rising trend in collaborations and partnerships.
• Expansion in emerging markets is a significant upcoming trend.
Major companies in the digital biomarkers market are:
• Pfizer Inc.
• Bayer AG
• F Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Koninklijke Philips NV (Philips)
• GE Healthcare
• Biogen Inc.
• Garmin Ltd.
• Clario
• Verily Life Sciences LLC
• Altoida Inc.
• BioSerenity
• Oura Health Oy.
• Evidation Health Inc.
• AliveCor Inc.
• Empatica Inc.
• ActiGraph LLC
• VivoSense Inc.
• BioSensics LLC
• Koneksa Health Inc.
• ATCOR Medical Pty Ltd.
• Brainomix Limited
North America was the largest region in the digital biomarkers market in 2024